Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026

Relmada Therapeutics (Nasdaq: RLMD) will report first quarter 2026 financial results and host a conference call and webcast on Tuesday, May 12, 2026 at 4:30 PM ET.

Rhea-AI Summary

Relmada Therapeutics (Nasdaq: RLMD) will report first quarter 2026 financial results and host a conference call and webcast on Tuesday, May 12, 2026 at 4:30 PM ET. The company will discuss results for the quarter ended March 31, 2026 and provide updates on recent business and clinical progress.

Participant dial-in numbers and a webcast link are provided; a replay will be available in the Investors section of the Relmada website.

Argus May 6 session

+6.94% close to close Open Argus

Details

News Market Reaction – RLMD

In the May 6 session, RLMD gained 6.94%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +6.9% in the session following this news. A strong positive reaction aligns with RLM...

Analysis

The stock moved +6.9% in the session following this news. A strong positive reaction aligns with RLMD’s elevated technical setup, trading above its 200-day MA at 7.35. Historically, earnings date notices have produced modest moves of -2.69% and +1.53%, so a large gain would mark a departure from past behavior. Investors have an effective S-3 resale registration in the background, which could influence liquidity dynamics around future catalysts.

Key Figures

Earnings call date: Tuesday, May 12, 2026 Earnings call time: 4:30 PM ET Quarter end date: March 31, 2026 +2 more

Earnings call date

Tuesday, May 12, 2026

Scheduled Q1 2026 financial results discussion

Earnings call time

4:30 PM ET

Start time for Q1 2026 conference call and webcast

Quarter end date

March 31, 2026

First quarter 2026 period end referenced in call notice

US dial-in

1-800-717-1738

Participant dial-in number for US callers

International dial-in

1-646-307-1865

Participant dial-in number for international callers

Previous Earnings date Reports

2 past events · Latest: Mar 12

Same Type 2 events

1. Mar 12

   Earnings date notice

   24h Move

   -2.7%

   Announcement of Q4 2025 results date and related conference call details.

2. Nov 07

   Earnings date notice

   24h Move

   +1.5%

   Scheduling of Q3 2025 results release and investor conference call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

central nervous system

1 terms

central nervous system medical

"a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders"

The central nervous system (CNS) is the body's main control center, made up of the brain and spinal cord, that processes information and directs movement, sensation and basic functions like breathing. For investors, CNS-related products and research matter because they face long development times, strict safety testing and regulatory hurdles; success or failure can dramatically affect a company’s costs, timelines and potential market value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CORAL GABLES, Fla., May 06, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced plans to host a conference call and webcast on Tuesday, May 12, 2026 at 4:30 PM ET to discuss financial results for the first quarter ended March 31, 2026, and recent business progress.

Conference Call and Webcast Information:

• Date: Tuesday, May 12, 2026 at 4:30 PM ET
• Participant Dial-in (US): 1-800-717-1738
• Participant Dial-in (International): 1-646-307-1865
• Webcast Access: Click Here

A replay of the webcast will be available in the Investors section of the Relmada website at https://www.relmada.com/investors/ir-calendar.

About Relmada Therapeutics, Inc.
Relmada Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for oncology and central nervous system conditions. Its lead candidates, NDV-01 and sepranolone, are advancing through mid-stage clinical development with the potential to address significant unmet needs.

For more information, visit www.relmada.com

Investor Contact:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com

Media Inquiries:
Corporate Communications
media@relmada.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Relmada (RLMD) report Q1 2026 financial results and host the webcast?

Relmada will report Q1 2026 results and host a webcast on May 12, 2026 at 4:30 PM ET. According to Relmada, the call will cover financial results for the quarter ended March 31, 2026 and recent business and clinical progress, with a replay available online.

How can investors join the Relmada (RLMD) conference call on May 12, 2026?

Investors can join the May 12, 2026 call via US dial-in 1-800-717-1738 or international 1-646-307-1865. According to Relmada, a live webcast link is provided and a replay will be posted in the Investors section of the company website.

Where will the Relmada (RLMD) webcast replay be posted after the May 12, 2026 call?

The webcast replay will be available in the Investors section of Relmada's website at https://www.relmada.com/investors/ir-calendar. According to Relmada, the replay will remain accessible after the live event for investor review and follow-up.

What topics will Relmada (RLMD) discuss during the May 12, 2026 quarterly call?

Relmada will discuss Q1 2026 financial results and recent business and clinical progress. According to Relmada, the call will cover results for the quarter ended March 31, 2026 and provide updates on the company's oncology and CNS clinical programs.

Is there an international dial-in option for Relmada's (RLMD) May 12, 2026 conference call?

Yes, an international dial-in number is provided: 1-646-307-1865. According to Relmada, both US and international dial-ins will connect participants to the live call and a webcast link is available for online access.